Drugs that contain Topiramate

1. List of Eprontia drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11433046 AZURITY Compositions and methods for treating epilepsy, seizures and other conditions
Aug, 2040

(17 years from now)

US11633374 AZURITY Compositions and methods for treating epilepsy, seizures and other conditions
Aug, 2040

(17 years from now)

Do you want to check out EPRONTIA patents from before 2022?

Market Authorisation Date: 05 November, 2021

Treatment: Indicated as adjunctive therapy for the treatment of partial-onset seizures, primary generalized tonic-clonic seizures, and seizures associated with lennox-gastaut syndrome in patients 2 years of age ...

Dosage: SOLUTION;ORAL

How can I launch a generic of EPRONTIA before it's patent expiration?
More Information on Dosage

EPRONTIA family patents

5

United States

2. List of Qudexy Xr drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10363224 UPSHER SMITH LABS Extended-release topiramate capsules
Mar, 2033

(9 years from now)

US8889190 UPSHER SMITH LABS Extended-release topiramate capsules
Mar, 2033

(9 years from now)

US9101545 UPSHER SMITH LABS Extended-release topiramate capsules
Mar, 2033

(9 years from now)

US9555005 UPSHER SMITH LABS Extended-release topiramate capsules
Mar, 2033

(9 years from now)

US8652527 UPSHER SMITH LABS Extended-release topiramate capsules
Mar, 2033

(9 years from now)

Do you want to check out QUDEXY XR patents from before 2022?

Market Authorisation Date: 11 March, 2014

Treatment: Treatment of seizures

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

How can I launch a generic of QUDEXY XR before it's patent expiration?
More Information on Dosage

QUDEXY XR family patents

12

United States

3

Korea, Republic of

1

Canada

1

Brazil

1

Israel

1

European Union

3. List of Trokendi Xr drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10314790 SUPERNUS PHARMS Sustained-release formulations of topiramate
Nov, 2027

(4 years from now)

US8992989 SUPERNUS PHARMS Sustained-release formulations of topiramate
Nov, 2027

(4 years from now)

US8889191 SUPERNUS PHARMS Sustained-release formulations of topiramate
Nov, 2027

(4 years from now)

US9549940 SUPERNUS PHARMS Sustained-release formulations of topiramate
Nov, 2027

(4 years from now)

US8298580 SUPERNUS PHARMS Sustained-release formulations of topiramate
Nov, 2027

(4 years from now)

US8877248 SUPERNUS PHARMS Sustained-release formulations of topiramate
Nov, 2027

(4 years from now)

US9555004 SUPERNUS PHARMS Sustained-release formulations of topiramate
Nov, 2027

(4 years from now)

US9622983 SUPERNUS PHARMS Sustained-release formulations of topiramate
Nov, 2027

(4 years from now)

US8663683 SUPERNUS PHARMS Sustained-release formulations of topiramate
Nov, 2027

(4 years from now)

US8298576 SUPERNUS PHARMS Sustained-release formulations of topiramate
Apr, 2028

(4 years from now)

Do you want to check out TROKENDI XR patents from before 2022?

Market Authorisation Date: 16 August, 2013

Treatment: Use of trokendi xr for the treatment of epilepsy; Use of trokendi xr for prophylactic treatment of migraine; Treatment of epilepsy

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

How can I launch a generic of TROKENDI XR before it's patent expiration?
More Information on Dosage

TROKENDI XR family patents

12

United States

2

Spain

2

European Union

1

Germany

1

Canada

1

Mexico

1

Australia

1

Japan

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic